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Abstract: The spectrum of pathology in native kidney biopsies varies considerably between different
countries. Based on similar biopsy policy and joint workup, biopsy data of native kidneys of children
in Yerevan (Armenia) and Zurich (Switzerland) were compared over a period of two decades (1993-2002
and 2003-2012). A total of 487 renal biopsies in Yerevan (EVN), n = 253; median age 11.2 years (range
0.8-18; 56 % males) and in Zurich (ZRH), n = 234; median age 8.7 years (range 0.1-18; 61 % males)
were analyzed. Biopsies from EVN were locally analyzed by light microscopy (LM) and sent to ZRH for
electron microscopy (EM) and immunohistochemistry. Biopsies from ZRH were evaluated by LM, EM,
and immunofluorescence. The significant difference concerns the high frequency of amyloidosis in EVN
(25.4 % in the first and 19.4 % in the second decade vs. 0 % in ZRH) and of IgA nephropathy in ZRH
(30.2 % in the first and 26.1 % in the second decade vs. 8.1 in EVN). Certain forms of glomerulonephritis
(membranoproliferative type I and membranous) and primary focal segmental glomerulosclerosis tended
to be more frequent in EVN than in ZRH. Amyloid nephropathy due to familial Mediterranean fever is
still highly frequent in Armenia with a slight decrease in the second decade. In Switzerland, the most
common finding was IgA nephropathy.
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Abstract The spectrum of pathology in native kidney
biopsies varies considerably between different countries.
Based on similar biopsy policy and joint workup, biop-
sy data of native kidneys of children in Yerevan
(Armenia) and Zurich (Switzerland) were compared over
a period of two decades (1993–2002 and 2003–2012). A
total of 487 renal biopsies in Yerevan (EVN), n=253;
median age 11.2 years (range 0.8–18; 56 % males) and
in Zurich (ZRH), n=234; median age 8.7 years (range
0.1–18; 61 % males) were analyzed. Biopsies from
EVN were locally analyzed by light microscopy (LM)
and sent to ZRH for electron microscopy (EM) and
immunohistochemistry. Biopsies from ZRH were evalu-
ated by LM, EM, and immunofluorescence. The signif-
icant difference concerns the high frequency of amyloid-
osis in EVN (25.4 % in the first and 19.4 % in the
second decade vs. 0 % in ZRH) and of IgA
nephropathy in ZRH (30.2 % in the first and 26.1 %
in the second decade vs. 8.1 in EVN). Certain forms of
glomerulonephritis (membranoproliferative type I and
memb r a no u s ) a n d p r ima r y f o c a l s e gmen t a l
glomerulosclerosis tended to be more frequent in EVN
than in ZRH. Amyloid nephropathy due to familial
Mediterranean fever is still highly frequent in Armenia
with a slight decrease in the second decade. In
Switzerland, the most common finding was IgA
nephropathy.
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Introduction
The diagnosis of many kidney diseases in children is
still based on renal biopsy despite the advances in
imaging and genetic diagnostics and is essential for
treatment and prognosis. Only limited data are available
on indication and histological spectrum of renal biopsy
findings in children regarding the comparison of differ-
ent countries, ethnic groups, time periods, and children
and adults [1–12]. More studies are available regarding
adult patients only, some evaluating a large number of
native kidney biopsies [13–16].
Following the earthquake of December 1988 in
Armenia, percutaneous renal biopsy was established in
Yerevan (EVN) in a partnership program with Zurich
(ZRH). The renal biopsy policy was similar at both
sites, and most biopsies from EVN (except mainly those
with amyloidosis) were also evaluated in ZRH.
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The aims of this study were (1) to compare biopsy findings
of both countries and (2) to look for trends over two decades.
Material and methods
From 1993 to 2012, 267 and 235 children underwent percu-
taneous native kidney biopsy in EVN (including five autop-
sies) and ZRH, respectively. Fourteen biopsies from EVN and
one from ZRH containing insufficient material were excluded,
resulting in a total of 487 eligible biopsies, with 253 from
EVN (141 boys and 112 girls; median age 11.2 years, range
0.8–18) and 234 from ZRH (142 boys and 92 girls; median
age 8.7 years, range 0.1–18). The children’s hospitals in EVN
and ZRH serve each a pediatric population (<18 years) of
approximately 800,000.
The clinical indications for renal biopsies were
(1) Nephrotic syndrome (steroid-resistant, associated with
hematuria and/or hypertension, impaired renal function
or extrarenal symptoms)
(2) Persistent marked proteinuria (>1.0 g/m2 per day)
(3) Persistent hematuria and proteinuria (<1.0 g/m2 per day)
(4) Recurrent (≥3) episodes of gross, non-urological
hematuria
(5) Acute kidney injury of unknown origin
(6) Only in Armenia: abnormal urinary findings in patients
with known familial Mediterranean fever (FMF). FMF
was diagnosed on history, clinical findings, and genetic
analysis.
The observation time of 20 years with 487 biopsies was
divided into two periods:
– Period I (1993–2002; n=210); n=114 for EVN, n=96 for
ZRH
– Period II (2003–2012; n=277); n=139 for EVN, n=138
for ZRH
Biopsies from EVN were first processed by light micros-
copy (LM) in EVN; 183 of them were additionally examined
in ZRH by LM, immunohistochemistry (IH, since 2005), and
electron microscopy (EM). Biopsies from ZRH were evaluat-
ed by LM, immunofluorescence (IF), and EM.
Renal biopsy processing
For light microscopy, biopsy specimens from ZRHwere fixed
in 4 % buffered formalin and processed routinely. Biopsies
from EVN were fixed in glutaraldehyde from 1993 to 2004
and in buffered formalin since 2005. Serial 2-μm-thick sec-
tions were cut and stained with hematoxylin and eosin,
methenamine silver, periodic acid-Schiff reagent, elastic van
Gieson, and acid fuchsin orange G-stain.
For immunofluorescence study, standard techniques were
applied to frozen sections using fluorescein isothiocyanate-
conjugated antisera to IgG, IgA, IgM, κ, and λ light chains,
C3, C1q (Dako, Glostrup, Denmark) as well as α3 and α5
type IV collagen (Euro Diagnostica, Malmö, Sweden).
For immunohistochemistry on paraffin sections, standard
procedures were applied using the Ventana BenchMark auto-
mated staining system with IgG, IgA, IgM, C3, and AA
amyloid antibodies (Dako, Glostrup, Denmark).
For transmission electronmicroscopy, the biopsy was fixed
in 2.5 % buffered glutaraldehyde, embedded in epon after
postfixation with osmium tetroxide. Semithin sections were
stained with methylene blue/azur II. Ultrathin sections were
stained with uranyl acetate and lead citrate. The probes were
examined using a Hitachi H-7650 TEM (Tokyo, Japan).
Statistical analysis was performed using unpaired t test for
independent groups. A p value <0.05 was considered statisti-




The main clinical findings leading to a renal biopsy are shown
in Table 1. Significantly more patients in EVN than in ZRH
were nephrotic (p<0.001). However, the largest subgroup of
nephrotic patients in EVN had FMF as the underlying disease.
Among the 80 Armenian patients with FMF and proteinuria,
47 were nephrotic. If all 80 patients with FMF are excluded
from analysis, the proportion of nephrotic syndrome (34.7 %)
is closer to the corresponding data from ZRH (25.6 %).
Renal biopsy findings
The most frequent histological diagnosis (Table 2) found in
Armenia was renal amyloidosis secondary to FMF, affecting
56 patients (22.1 %). The remaining 24 patients with known
FMF had other renal involvement than amyloidosis. Renal
amylo idos i s was fo l lowed by foca l s egmen ta l
glomerulosclerosis (FSGS, 13.4 %) and minimal change ne-
phrotic syndrome (MCNS, 10.3 %). Examples of renal biopsy
findings in patients with and without FMF are shown in Fig. 1.
In ZRH, the most frequent diagnosis was IgA nephropathy
(IgAN; 27.8 %), either isolated (18.8 %) or associated with
Henoch-Schönlein purpura (HSP; 9.0 %), followed byMCNS
(10.7 %) and FSGS (9.8 %). Only one child was clinically and
genetically diagnosed with FMF, however, the histology
showed no amyloidosis, but FSGS.
78 Virchows Arch (2015) 466:77–83
Table 1 Clinical findings.
Armenian patients with familial
Mediterranean fever (FMF) are
listed separately
Main clinical findings Yerevan (n=253) Zurich (n=234)
Nephrotic syndrome (NS) 107 (42 %) 60 (26 %)
FMF excluded FMF detected
n=173 n=80
Steroid-resistant 38 – 34
Steroid-sensitive, but dependant 3 – 6
NS combined with hematuria and/or renal insufficiency 15 – 15
NS in patients with other extrarenal symptoms 4 – 4
NS in patients with FMF (familial Mediterranean fever) – 47 1
Non-nephrotic patients 146 (58 %) 174 (74 %)
Urinary abnormality (proteinuria±hematuria) 50 25 102
Nephritic syndrome 28 3 34
Acute kidney injury 9 1 14
Rapidly progressive GN 18 2 15
Chronic renal insufficiency 8 2 9
Table 2 Renal pathology. Percentages for Yerevan are shown for all patients and after exclusion of FMF. Significantly higher percentages (p<0.05) in
Yerevan or Zurich are italicized
Histology Yerevan (EVN) Zurich (ZRH)
All patients Excluding FMF patients All patients
n % n % n %
Amyloidosis 56 22.1 80 0 0 0
Minimal change nephrotic syndrome (MCNS) 26 10.3 18 10.4 25 10.7
Focal segmental glomerulosclerosis (FSGS) 34 13.4 30 17.3 23 9.8
Diffuse mesangial sclerosis (DMS) 3 1.2 3 1.7 6 2.6
Acute postinfectious glomerulonephritis (APGN) 13 5.1 7 4 13 5.6
Membranoproliferative GN type I (MPGN I) 15 5.9 14 8.1 8 3.3
Dense deposit disease (DDD) 6 2.4 6 3.5 6 2.6
C3-glomerulonephritis 0 0 0 0 3 1.3
Membranous nephropathy (MN) 12 4.7 12 6.9 4 1.7
IgA nephropathy (IgAN) 12 4.7 10 5.8 44 18.8
IgAN associated with Henoch-Schönlein purpura (HSP) 9 3.6 8 4.6 21 9.0
Systemic lupus erythematosus (SLE) 19 7.5 19 11.0 10 4.3
Thrombotic microangiopathy (TMA), hemolytic
uremic syndrome (HUS)
8 3.3 8 4.6 10 4.3
Vasculitis ANCA-associated 3 1.2 3 1.7 8 3.3
Thin basement membrane disease (TBMD) 7 2.8 6 3.5 14 6.0
Alport syndrome 15 5.9 15 8.7 5 2.1
Acute tubular necrosis (ATN) 0 0 0 0 8 3.4
Tubulointerstitial nephritis (TIN) 2 0.8 1 0.6 6 2.6
Other 2 a 0.8 2 1.2 10 b 4.3
No pathology 0 0 0 0 6 2.6
Not diagnostic 11 4.3 11 6.4 4 1.7
Total 253 100 173 100 234 100
aOne patient each with nephronophthisis and lymphoma
bOne patient each with nephronophthisis, Joubert syndrome, renal-hepatic-pancreatic dysplasia, tubular dysgenesis, Finnish type nephrotic syndrome,
lymphoma, C1q-nephropathy, arteriolar hyalinosis, and two patients with Fabry disease
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Comparison between Yerevan and Zurich
As expected, amyloidosis secondary to FMF was the most
frequent renal pathology (22.1 %) in EVN. In contrast, no
amyloidosis was diagnosed in ZRH. This disease is very
specific for some ethnic groups (Armenians, non-Ashkenazi
Jews, Arabs, Turks) and extremely rare in Europe. The age at
onset of FMF was 3.2±3 years (range 0.3–14) and the age at
biopsy was 12.0±3.9 years (range 5–18). Forty-four of the 47
nephrotic patients with FMF from EVN had amyloidosis, two
had MCNS, and one had FSGS. Out of the 33 non-nephrotic
patients with FMF, 12 had amyloidosis, six each had MCNS
and acute postinfectious glomerulonephritis (APGN), three
had FSGS, two had isolated IgAN, and one each had
Fig. 1 Examples of renal biopsy findings in biopsies from EVN after
exclusion of FMF (a–c NS, d–e no NS) and in FMF (g–i NS, j–l no NS).
a–cAlport syndrome: a segmental sclerotic lesions, b irregularities of the
glomerular basement membrane (GBM) with splitting, c splitting and
multilamellation of the GBM (a–b methenamine silver, original magni-
fication a ×200, b ×400, c TEM, original magnification ×13,500). d–f
Dense deposit disease: d–e thickened, glassy GBM, f highly osmiophilic
dense deposits in the GBM (d periodic acid-Schiff reagent, original
magnification ×240, e methenamine silver, original magnification ×240,
f TEM, original magnification ×1950). g–i Postinfectious
glomerulonephritis: g endocapillary proliferation, h C3-positive chunky
subepithelial deposits (→), i subepithelial “humps” (→) (g hematoxylin
and eosin, original magnification ×160, h C3 immunostaining, original
magnification ×200, i TEM, original magnification ×5800). j-l IgA
nephropathy: j mesangial and endocapillary proliferation and a cellular
crescent, k IgA-positive mesangial deposits, l mesangial electron dense
deposits (j periodic acid-Schiff reagent, original magnification ×160, k
IgA immunostaining, original magnification ×320, l TEM, original mag-
nification ×4000)
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membranoproliferative glomerulonephritis type I (MPGN I),
HSP, thin basement membrane disease (TBMD), and
tubulointerstitial nephritis.
In order to allow a closer comparison, both series were
further analyzed after exclusion of the Armenian patients with
FMF (Table 2). In contrast to renal amyloidosis, IgAN was
seen significantly more often in ZRH than in EVN, particu-
larly the isolated form (p<0.001). IgAN associated with HSP
tended also to be more frequent in ZRH. Glomerulonephritis
(GN) secondary to systemic lupus erythematosus (SLE) was
more prevalent in EVN than in ZHR (p<0.05); 15 of the 19
Armenian patients were females. MPGN I, membranous ne-
phritis (MN; p<0.05) and the Alport syndrome (p<0.01) were
seenmore often in EVN than in ZRH. Two patients from ZRH
were diagnosed with C3 glomerulonephritis, in one of them
the diagnosis was made by re-biopsy.
Comparison between the two time periods (Figs. 2a, b)
The proportion of patients showing IgAN in EVN in-
creased from 6.1 to 10.1 %, mainly due to isolated IgAN
(Fig. 2a). However, IgAN (both isolated and associated with
HSP) was observed far more often in ZRH and has remained
the most prevalent diagnosis despite a minor decline from
30.2 % in the first to 26.1 % in the second decade (Fig. 2b).
Only in EVN, a trend was observed suggesting an increase
of patients with FSGS, which however did not reach statistical
significance (calculated as t test). In contrast, the percentage of
patients with amyloidosis slightly decreased, but the absolute
number of patients (29 versus 27) remained largely
unchanged.
Discussion
This study provides data on renal biopsy findings in pediatric
patients of two different countries. Of special interest is the
direct comparison, made possible by similar policy for
performing renal biopsies and by biopsy evaluation at the
same pathology service.
The most obvious difference concerns the very large num-
ber of patients in EVN suffering from renal amyloidosis due to
FMF. This is an unusual proportion, even in countries with a
large number of FMF. For example, not a single patient with
amyloidosis has been reported in Saudi Arabia among 128
children with the nephrotic syndrome [1]. FMF constitutes in
fact a major health problem in Armenia with a carrier rate
being as high as 1:5 [17]. Renal amyloidosis is largely a
preventable condition, if FMF is diagnosed early and colchi-
cine is administered regularly. The alarmingly high number of
patients with amyloidosis in our series is due to the absence of
systematic prophylactic measures until 2002 as a result of the
economic crisis and major disturbances of the health care in
Armenia.
However, even with established amyloidosis some ne-
phrotic patients may go into partial or even full remission after
administration of colchicine, but the response is not predict-
able [18]. As compared to the first period, there was a slight
decline in the second period (2003–2012) and it is expected
that the number of renal amyloidosis will considerably de-
crease over the next years.
Apart of amyloidosis, some other renal diseases have been
observed in patients with FMF, as FMF is known to be weakly
associated with various forms of GN, but in at least MCNS,
FSGS, and APGN, it was probably coincidental.
Nevertheless, it is known that FMF predisposes to different
types of vasculitis (e.g., polyarteritis nodosa, HSP), often with
serious renal lesions and rapid progression [19–21]. A special
group comprises 12 FMF patients with proteinuria or the
nephrotic syndrome without hematuria—thus mimicking am-
yloid nephropathy—were found to have MCNS or FSGS.
A considerably higher proportion of patients with
IgAN (either isolated or associated with HSP) was ob-
served in ZRH as compared to EVN. The question arises
whether IgAN and HSP are really more frequent in ZRH.
Although biopsies from EVN were not examined by IH
till 2005, we do not think that isolated IgAN was grossly
Fig. 2 a Comparison of selected diagnoses in two decades in Yerevan (as
% of all patients per period). b Comparison of selected diagnoses in two
decades in Zurich (as % of all patients per period)
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underdiagnosed in EVN. In fact, histological findings as
mesangial proliferation, mesangial electron dense deposits
without hump-like subepithelial or intramembranous
highly dense deposits allow a presumptive diagnosis of
IgAN in the context of hematuria, even without IF or IH
[22]. Another reason explaining the lower number of
IgAN in EVN, particularly during the first time period,
is the late referral rate of patients. In contrast to isolated
IgAN, diagnosis of HSP is based on clinical symptoms,
and in general, no renal biopsy was done if renal function
remained normal. The number of patients requiring renal
biopsies may strongly fluctuate, as has been demonstrated
in ZRH. In the literature, the frequency of IgAN among
pediatric biopsies strongly depends on study design and
the corresponding health care system. There is a rather
lower rate in the USA or Europe [23] compared with
countries as Korea or Japan, where a considerably higher
proportion of IgAN is diagnosed most often initiated by
general mass school urine screening [6, 24].
The number of biopsies in APGN was similar in both
countries, although over 600 pediatric patients were seen in
EVN during the study period [25]. However, a renal biopsy is
rarely needed since the course of APGN in children is usually
self-limited.
The true incidence of MCNS is far higher than diagnosed
in our study, as the indication for biopsy was limited to
steroid-resistant nephrotic syndrome. If biopsies are per-
formed in all nephrotic children, the incidence of MCNS is
reported to be higher [10].
Our data do not demonstrate an increasing trend of FSGS
during the last two decades, as had been suggested not only in
adults [14, 15], but also in children [26].
The lower number of MPGN I in ZRH as compared to
EVN could be an effect of the overall decrease of MPGN I
observed over the last few decades in adult patients, first in
industrialized and later in developing countries [13, 27]. The
larger number of biopsies showing SLE in EVNmight be real,
as the prevalence of SLE is likely to be higher in Armenia than
in Central Europe [28].
This study only included biopsy-proven renal diseases and
therefore does not reflect the whole spectrum of pediatric renal
disorders. Indeed, some hereditary renal disorders are diag-
nosed by genetic analysis (e.g., autosomal dominant polycys-
tic kidney disease, cystinosis, Dent’s disease, Lowe
syndrome).
In conclusion, the present study allows a direct com-
parison between renal biopsy findings of two countries
and two different time periods. The most obvious find-
ing was the high incidence of amyloidosis secondary to
FMF in Armenia, whereas IgAN was more prevalent in
Zurich. Considerable differences between the first and
the second observation decades have been observed for
certain glomerular diseases. While the proportion of
IgAN in Armenia increased, a decreasing trend of pa-
tients with amyloidosis was observed.
Conflict of interest All authors shall disclose possible conflicts of
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